Researchers from East China Normal University have developed a probiotic that can sense and respond to glucose levels, potentially transforming type 2 diabetes treatment. This innovative approach utilizes engineered Escherichia coli to deliver glucagon-like peptide 1 (GLP-1) onl…
A California shopper's viral reaction to a 'GLP-1-friendly' frozen pizza has raised questions about the implications of such labeling. The pizza, part of Nestlé's Vital Pursuit li…
The death of 19-year-old Josephine Nasr, a law student in London, has sparked serious concerns regarding the safety of tirzepatide, a GLP-1 weight loss drug. Following her prescri…
Nestle is leveraging the rise of GLP-1 weight-loss drugs to create new products aimed at consumers taking medications like Ozempic and Wegovy. The company is utilizing artificial…
Older adults taking GLP-1 medications such as Ozempic and Wegovy should focus on adequate protein, calcium, and vitamin D intake to maintain muscle and bone health during weight l…
Recent studies suggest that GLP-1 medications, known for their role in managing Type 2 diabetes and weight loss, may also help reduce cravings and substance use in addiction treat…
Researchers at the University of Cambridge have discovered that both activating and blocking the glucose-dependent insulinotropic polypeptide receptor (GIPR) in different brain re…
The emergence of GLP-1 weight loss drugs, such as Ozempic and Wegovy, has transformed the landscape of obesity treatment, generating significant revenue for manufacturers and spar…
Recent research has revealed that semaglutide, a popular weight-loss drug, may operate through mechanisms involving hunger neurons, challenging previous understandings of its effe…
As GLP-1 medications gain popularity among U.S. adults, health and fitness coaches are adapting their approaches to support clients using these drugs. This article explores seven…
Recent research indicates that GLP-1 agonists, such as Ozempic, may not only aid in weight loss but also reduce cravings for addictive substances like alcohol. This effect is link…
Chrissy Metz shares her experience with GLP-1 medications, discussing how they helped her manage food cravings and achieve weight loss. She emphasizes the complexities of obesity…
Beauty industry leaders are ramping up efforts to develop treatments specifically designed for those experiencing facial volume loss, promising to redefine the standards of beauty…
Novo Nordisk's stock fell by 7% after the company revealed its long-term growth strategy at a capital markets day, raising investor concerns about its ability to maintain its posi…
In a stunning twist of regulatory fate, the FDA has issued new hair-raising guidelines for users of GLP-1 drugs like Ozempic and Mounjaro, warning of a 37-68% increased risk of ha…